Literature DB >> 20426776

Reticular grey-blue areas of regression as a dermoscopic marker of melanoma in situ.

S Seidenari1, C Ferrari, S Borsari, E Benati, G Ponti, S Bassoli, F Giusti, S Schianchi, G Pellacani.   

Abstract

BACKGROUND: By dermoscopy, regression structures are substantially defined by the presence of white and blue areas in the lesion image. As fibrosis and melanosis are often seen in malignant melanoma (MM), the presence of dermoscopic signs of regression may represent a clue for the diagnosis of malignancy.
OBJECTIVES: To assess the frequency and extent of dermoscopic signs of regression in melanoma in situ (MIS) and to describe its dermoscopic features.
METHODS: Dermoscopic images of 85 MIS, 85 invasive MMs and 85 dermoscopically equivocal lesions with a histological diagnosis of naevus were evaluated by three dermatologists, who assessed the presence of 11 parameters of regression.
RESULTS: The number of regression parameters per lesion increased according to melanoma thickness. White areas, the grey-blue veil and widespread blue areas were more frequent in invasive MMs than in the other two lesion groups, whereas light brown areas and regression of dermoscopic structures were more frequent in MIS. Peppering was observable in the same percentage of MIS and invasive MMs. Blue areas were more frequently structureless in equivocal lesions and invasive MMs, whereas the reticular pattern prevailed in MIS.
CONCLUSIONS: Frequency, morphology, extent and distribution of regression vary according to melanoma thickness and diameter. Lesions with reticular blue regression and light brown areas should undergo surgical excision for the suspicion of MIS. Moreover, the identification of the reticular pattern of blue regression can be considered a significant discriminator and a reliable predictor of MIS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20426776     DOI: 10.1111/j.1365-2133.2010.09821.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Dermoscopic features of thin melanomas: a comparative study of melanoma in situ and invasive melanomas smaller than or equal to 1mm.

Authors:  Vanessa Priscilla Martins da Silva; Juliana Kida Ikino; Mariana Mazzochi Sens; Daniel Holthausen Nunes; Gabriella Di Giunta
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ.

Authors:  Aimilios Lallas; Caterina Longo; Marco Manfredini; Elisa Benati; Graziella Babino; Chiara Chinazzo; Zoe Apalla; Chryssoula Papageorgiou; Elvira Moscarella; Athanassios Kyrgidis; Giuseppe Argenziano
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

Review 3.  Reporting regression with melanoma in situ: reappraisal of a potential paradox.

Authors:  Alexander M Cartron; Paola C Aldana; Amor Khachemoune
Journal:  Arch Dermatol Res       Date:  2020-07-06       Impact factor: 3.017

4.  Fuzzy logic color detection: Blue areas in melanoma dermoscopy images.

Authors:  Mounika Lingala; R Joe Stanley; Ryan K Rader; Jason Hagerty; Harold S Rabinovitz; Margaret Oliviero; Iqra Choudhry; William V Stoecker
Journal:  Comput Med Imaging Graph       Date:  2014-04-03       Impact factor: 4.790

5.  Interobserver Agreement on Dermoscopic Features and their Associations with In Situ and Invasive Cutaneous Melanomas.

Authors:  Sam Polesie; Lisa Sundback; Martin Gillstedt; Hannah Ceder; Johan Dahlén Gyllencreutz; Julia Fougelberg; Eva Johansson Backman; Jenna Pakka; Oscar Zaar; John Paoli
Journal:  Acta Derm Venereol       Date:  2021-10-14       Impact factor: 3.875

6.  Pigmented nodular Basal cell carcinomas in differential diagnosis with nodular melanomas: confocal microscopy as a reliable tool for in vivo histologic diagnosis.

Authors:  Alice Casari; Giovanni Pellacani; Stefania Seidenari; Anna Maria Cesinaro; Francesca Beretti; Patrizia Pepe; Caterina Longo
Journal:  J Skin Cancer       Date:  2010-10-14

7.  Grey-blue regression in melanoma in situ-evaluation on 111 cases.

Authors:  S Bassoli; S Borsari; C Ferrari; F Giusti; G Pellacani; G Ponti; S Seidenari
Journal:  J Skin Cancer       Date:  2011-03-23

8.  Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Lavinia Ferrante di Ruffano; Rubeta N Matin; David R Thomson; Kai Yuen Wong; Roger Benjamin Aldridge; Rachel Abbott; Monica Fawzy; Susan E Bayliss; Matthew J Grainge; Yemisi Takwoingi; Clare Davenport; Kathie Godfrey; Fiona M Walter; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-04

9.  Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics.

Authors:  Stefania Seidenari; Federica Arginelli; Christopher Dunsby; Paul M W French; Karsten König; Cristina Magnoni; Clifford Talbot; Giovanni Ponti
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Patterns of Change During the Dermoscopic Follow-Up of Melanocytic Lesions in High Risk Patients.

Authors:  Loredana Ungureanu; Alina Letcă; Simona Corina Șenilă; Ana Sorina Dănescu; Rodica Cosgarea
Journal:  Clujul Med       Date:  2015-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.